Komori
TAUNS Laboratories (197A) · InitiativeAdvanced

Clinical testing contract services provided by タウンズクリニカルラボ

First written in FY2025. 3 of 4 entries say "Advanced", first in 2026-07-15. Latest entry: FY2026.

4entries
2years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2025Advanced2026-07-15 – FY20262025: 120252026: 32026
Same theme, other companies
Contract Testing Services through a Company-Owned Clinical Testing CenterA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「The Clinical Laboratory Division has also begun providing contract clinical testing services.」

    The company progressed from the preparation stage for the launch described in the previous fiscal year to the launch stage for contract clinical testing services provided by タウンズクリニカルラボ. Advanced services, including the introduction of next-generation sequencers and whole-genome analysis, are also planned.
  3. FY2025First statedAnnual report

    「The Clinical Laboratory Department is preparing to launch contract clinical laboratory testing services. In addition to providing proprietary testing services through contract testing, we will gain a deeper understanding of issues and needs in clinical settings and use this knowledge in research and development.」

    The company is investing in Towns Clinical Lab, its wholly owned testing center, positioning contract clinical laboratory testing as a new service and a source of information for R&D.
Moved together

"IP and Technology Partnership Investments Toward the 10-Year Business Vision" moved the same way as this thread, in the same document, in 3 of its 4 moves.

322222★123456
  1. ★This thread
  2. 1IP and Technology Partnership Investments Toward the 10-Year Business Vision3×
  3. 2Development of New Core Technologies and an Inspection Platform2×
  4. 3Expansion into non-infectious disease areas, including chronic diseases, cancer and kidney disease2×
  5. 4Overseas Expansion Through Distributor Networks, Overseas-Market Products and High-Value-Added Products2×
  6. 5Stable, Sustained Dividends Based on a Payout Ratio of Approximately 30%2×
  7. 6Productivity Gains Through a New Core Business System and Medical Data Platform2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for TAUNS Laboratories yet. It last moved in the Business Alliances of 2026-08-20: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Clinical testing contract services provided by タウンズクリニカルラボ | TAUNS Laboratories,Inc. (197A) | Komori